$SRNE

Sorrento Therapeutics Inc.

  • NASDAQ
  • Health Technology
  • Biotechnology

PRICE

$6.78 ▼-1.022%

Extented Hours

VOLUME

24,141,312

DAY RANGE

6.43 - 7.07

52 WEEK

1.39 - 10

Echofin Members Consensus

profile
zonatrading #Zona Trading
recently

Yo shortie el martes SRNE porque ya lo he visto anteriormente, no compraria esa porqueria jamas aunque me equivoque y si tengan la cura.

profile
zonatrading #Zona Trading
recently

Ejemplo claro de eso: SRNE el lunes hizo un press release diciendo que tenian bastante avance para la vacuna.

Key Metrics

Market Cap

1.38 B

Beta

0.53

Avg. Volume

28.46 M

Shares Outstanding

202.12 M

Yield

0%

Public Float

161.06 M

Next Earnings Date

Next Dividend Date

Company Information

Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates. The company was founded by Henry H. Ji in 2006 and is headquartered in San Diego, CA.

CEO: Henry H. Ji

Website:

HQ: 4955 Directors Place San Diego, 92121 CA

Related News

  • PR Newswire

    Thinking about buying stock in Sorrento Therapeutics, Zomedica Pharmaceuticals, TOP Ships, Nokia, or Microsoft Corp?

    02 Jul 2020, 14:45
  • Coinspeaker

    Why Vaxart, Inovio, Sorrento Therapeutics Stocks Took Off on Thursday

    26 Jun 2020, 12:38
  • The Motley Fool

    Why Vaxart, Inovio, and Sorrento Therapeutics Stocks Soared Today | The Motley Fool

    25 Jun 2020, 22:12
  • PR Newswire

    Thinking about buying stock in Sorrento Therapeutics, Rite Aid Corp, Inovio Pharmaceuticals, Seanergy Maritime Holdings, or United Airlines?

    25 Jun 2020, 13:31
  • Business Wire

    Shareholder Alert: Robbins LLP Reminds Investors Sorrento Therapeutics, Inc. (SRNE) Sued for Misleading Shareholders

    17 Jun 2020, 19:51